Cna Financial Corp Axonics, Inc. Transaction History

Cna Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$59.56 - $76.6 $288,389 - $370,897	-4,842 Reduced 43.24%	6,356 $397,000
Q3 2022 Nov 10, 2022	SELL	$57.96 - $78.12 $106,878 - $144,053	-1,844 Reduced 14.14%	11,198 $789,000
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $46,282 - $56,495	1,097 Added 9.18%	13,042 $651,000
Q2 2020 Aug 13, 2020	BUY	$22.91 - $39.83 $273,659 - $475,769	11,945 New	11,945 $419,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.